{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:48:49Z","timestamp":1791557329866,"version":"4.3.4"},"reference-count":42,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["37\/1743\/23\/EMR-II"],"award-info":[{"award-number":["37\/1743\/23\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["DST\/CSRI\/2021\/7"],"award-info":[{"award-number":["DST\/CSRI\/2021\/7"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/003884"],"award-info":[{"award-number":["CRG\/2022\/003884"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR39540\/ICD\/88\/4\/2021"],"award-info":[{"award-number":["BT\/PR39540\/ICD\/88\/4\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/CSRI\/2021\/7"],"award-info":[{"award-number":["DST\/CSRI\/2021\/7"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","award":["R.12020\/02\/2024-HR\/E-Office:829285"],"award-info":[{"award-number":["R.12020\/02\/2024-HR\/E-Office:829285"]}],"id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Toll-like receptors (TLRs) are key pattern recognition receptors that play a central role in regulating and bridging both innate and adaptive immune responses. Notably, TLR7 and TLR8 agonists have gained significant attention as promising therapeutic candidates because of their ability to activate immune responses and modulate immune signaling pathways for treating viral infections, autoimmune disorders, and cancer. Despite the growing interest in the area of immunotherapy, there remains a substantial gap in the development of new immunomodulators with improved efficacy and safety profiles. The primary objective of the study was to identify and evaluate newly synthesized TLR7\/8 agonists using integrated in silico and in vivo strategies. Computational analyses, including molecular docking, molecular dynamics (MD) simulations, pharmacokinetic-pharmacodynamic profiling, and network pharmacology analysis, revealed favorable binding interactions, stability, drug-like properties, and potential targeting of immune- and cancer-related pathways, specifically those relevant to colorectal cancer. In vitro cytotoxicity assays showed that the TLR7\/8 agonists exhibit dose-dependent effects in both colorectal cancer cells and RAW 264.7 macrophages. Additionally, the compounds exhibit minimal hemolytic activity, indicating a low potential for systemic toxicity. Furthermore, the cell migration assay demonstrated that several compounds effectively inhibited cancer cell migration, particularly when combined with 5-fluorouracil (5-FU), suggesting potential anticancer and antimetastatic activity. Overall, these findings integrate molecular-level, system-level, and experimental validation approaches to comprehensively evaluate TLR7\/8 agonists as potential immunotherapeutic agents. However, further comprehensive in vitro and in vivo investigation studies are necessary to establish the potential of TLR7\/8 agonists for use in cancer immunotherapy.<\/jats:p>","DOI":"10.1021\/acsptsci.6c00263","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:01:24Z","timestamp":1789732884000},"page":"2821-2841","source":"Crossref","is-referenced-by-count":0,"title":["Integrated\n                    <i>In Silico<\/i>\n                    and Experimental\nInsights into Immunomodulatory Toll-Like Receptor 7\/8 Agonists with\nAnticancer Potential"],"prefix":"10.1021","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4596-7539","authenticated-orcid":true,"given":"Pankaj","family":"Kumar","sequence":"first","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid Bashir","family":"Zargar","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj Pratap","family":"Singh","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushvinder","family":"Kumar","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Sihag","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Debaje","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research , , , ,","place":["SAS Nagar, Punjab, India, 160062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0259-9956","authenticated-orcid":true,"given":"Abhay T.","family":"Sangamwar","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research , , , ,","place":["SAS Nagar, Punjab, India, 160062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavitra","family":"Ranawat","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-145X","authenticated-orcid":true,"given":"Gurpal","family":"Singh","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Pratap","family":"Barnwal","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak B.","family":"Salunke","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]},{"name":"National Institute of Pharmaceutical Education and Research , , SAS Nagar, , ,","place":["Mohali, Punjab, India, 160062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-1435","authenticated-orcid":true,"given":"Sandip V.","family":"Pawar","sequence":"additional","affiliation":[{"name":"Panjab University , , ,","place":["Chandigarh, India, 160014"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"11","key":"2026100909105801400_cit1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/13543776.2025.2556819","article-title":"Toll-like\nreceptor agonists as cancer therapeutics: A patent review (2014-2024)","volume":"35","author":"Kumar","year":"2025","journal-title":"Ther. Pat"},{"key":"2026100909105801400_cit2","doi-asserted-by":"publisher","first-page":"1157023","DOI":"10.1155\/2021\/1157023","article-title":"Toll-Like Receptors\n(TLRs): Structure, Functions, Signaling,\nand Role of Their Polymorphisms in Colorectal Cancer Susceptibility","volume":"2021","author":"Sameer","year":"2021","journal-title":"Biomed. Res. Int"},{"key":"2026100909105801400_cit3","doi-asserted-by":"publisher","first-page":"114316","DOI":"10.1016\/j.bcp.2020.114316","article-title":"Detection of Viral Infections by Innate Immunity","volume":"183","author":"Carty","year":"2021","journal-title":"Biochem. Pharmacol"},{"key":"2026100909105801400_cit4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-022-00436-7","article-title":"Targeting Toll-Like Receptor 7\/8 for Immunotherapy:\nRecent Advances and Prospectives","volume":"10","author":"Sun","year":"2022","journal-title":"Biomark. Res"},{"key":"2026100909105801400_cit5","doi-asserted-by":"publisher","first-page":"24932","DOI":"10.18632\/oncotarget.15326","article-title":"The TLR7\nAgonist Imiquimod Induces Anti-Cancer Effects via Autophagic Cell\nDeath and Enhances Anti-Tumoral and Systemic Immunity during Radiotherapy\nfor Melanoma","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"2026100909105801400_cit6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1501-z","article-title":"Gastric Cancer Vaccines\nSynthesized Using a TLR7 Agonist and Their Synergistic Antitumor Effects\nwith 5-Fluorouracil","volume":"16","author":"Wang","year":"2018","journal-title":"J. Transl. Med"},{"key":"2026100909105801400_cit7","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1158\/1535-7163.MCT-09-1198","article-title":"Antitumor Activity\nand Immune Response\nInduction of a Dual Agonist of Toll-Like Receptors 7 and 8","volume":"9","author":"Wang","year":"2010","journal-title":"Mol. Cancer Ther"},{"key":"2026100909105801400_cit8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fphar.2017.00304","article-title":"Anti-Tumor Activity of Toll-Like Receptor 7 Agonists","volume":"8","author":"Chi","year":"2017","journal-title":"Front. Pharmacol"},{"issue":"5","key":"2026100909105801400_cit9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.molimm.2009.11.003","article-title":"A five-amino-acid\nmotif in the undefined region of the TLR8 ectodomain is required for\nspecies-specific ligand recognition","volume":"47","author":"Liu","year":"2010","journal-title":"Mol. Immunol"},{"issue":"10","key":"2026100909105801400_cit10","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.4049\/jimmunol.177.10.6584","article-title":"Cutting Edge: Activation of Murine\nTLR8 by a Combination\nof Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides","volume":"177","author":"Gorden","year":"2006","journal-title":"J. Immunol"},{"issue":"2","key":"2026100909105801400_cit11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3892\/mmr.2015.4668","article-title":"Molecular Cloning and Functional Characterization of\nMurine Toll-Like Receptor 8","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep"},{"issue":"2","key":"2026100909105801400_cit12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4049\/immunohorizons.2000002","article-title":"TLR7 and TLR8 Differentially Activate the IRF and NF-\u03baB\nPathways in Specific Cell Types to Promote Inflammation","volume":"4","author":"Bender","year":"2020","journal-title":"ImmunoHorizons"},{"issue":"4","key":"2026100909105801400_cit13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1208\/s12248-021-00620-x","article-title":"Employing Drug Delivery\nStrategies To Overcome Challenges Using TLR7\/8 Agonists for Cancer\nImmunotherapy","volume":"23","author":"Varshney","year":"2021","journal-title":"Aaps J"},{"key":"2026100909105801400_cit14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jconrel.2020.11.013","article-title":"Development of Thermosensitive Resiquimod-Loaded\nLiposomes for Enhanced Cancer Immunotherapy","volume":"330","author":"Zhang","year":"2021","journal-title":"J. Controlled Release"},{"key":"2026100909105801400_cit15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12645-021-00094-8","article-title":"Delivery of Cisplatin and Resiquimod in Nanomicelles\nfor the Chemoimmunotherapy\nof Ovarian Cancer","volume":"13","author":"Yin","year":"2022","journal-title":"Cancer Nanotechnol"},{"key":"2026100909105801400_cit16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/vaccines11020277","article-title":"The Role of\nTLR7\/8 Agonists in Cancer Therapy, with\nSpecial Emphasis on Hematologic Malignancies","volume":"11","author":"Les\u0301niak","year":"2023","journal-title":"Vaccines"},{"key":"2026100909105801400_cit17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1021\/acsptsci.4c00163","article-title":"Design and Synthesis\nof Polyphenolic Imidazo[4,5-c]quinoline\nDerivatives to Modulate Toll-Like Receptor-7 Agonistic Activity and\nAdjuvanticity","volume":"7","author":"Kumar","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci"},{"key":"2026100909105801400_cit18","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1021\/acsmedchemlett.4c00200","article-title":"Modulation of the Adjuvant Potential of Imidazoquinoline-Based\nTLR7\/8 Agonists via Alum Adsorption","volume":"15","author":"Kumar","year":"2024","journal-title":"ACS Med.\nChem. Lett"},{"key":"2026100909105801400_cit19","doi-asserted-by":"publisher","first-page":"7955","DOI":"10.1021\/jm500744f","article-title":"Determinants of Activity at Human\nToll-Like Receptors\n7 and 8: Quantitative Structure-Activity Relationship (QSAR) of Diverse\nHeterocyclic Scaffolds","volume":"57","author":"Yoo","year":"2014","journal-title":"J. Med. Chem"},{"key":"2026100909105801400_cit20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.6026\/97320630012062","article-title":"Molecular\nModeling and Docking of\nSmall Molecule Inhibitors against NEK2","volume":"12","author":"Ramachandran","year":"2016","journal-title":"Bioinformation"},{"key":"2026100909105801400_cit21","doi-asserted-by":"publisher","first-page":"101550","DOI":"10.1016\/j.jics.2024.101550","article-title":"In Silico\nExploration of Potential Indoleamine 2,3-Dioxygenase-1 Inhibitors:\nAn Insight from Docking, ADME, and Molecular Dynamic Simulations","volume":"102","author":"Zargar","year":"2025","journal-title":"J. Indian Chem. Soc"},{"key":"2026100909105801400_cit22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.46542\/pe.2022.221.336347","article-title":"Using GastroPlus\nto Teach Complex Biopharmaceutical Concepts","volume":"22","author":"Silva","year":"2022","journal-title":"Pharm Educ"},{"key":"2026100909105801400_cit23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-023-00689-4","article-title":"In Silico\nPrediction of Bioequivalence\nof Atorvastatin Tablets Based on GastroPlusTM Software","volume":"24","author":"Wang","year":"2023","journal-title":"BMC Pharmacol. Toxicol"},{"key":"2026100909105801400_cit24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-021-01987-y","article-title":"Experimental Solubility, Thermodynamic\/Computational\nValidations, and GastroPlus-Based In Silico Prediction for Subcutaneous\nDelivery of Rifampicin","volume":"22","author":"Mahdi","year":"2021","journal-title":"AAPS Pharm. Sci. Technol"},{"key":"2026100909105801400_cit25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and\nComputational Approaches to Estimate Solubility and Permeability in\nDrug Discovery and Development Settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv.\nDrug Delivery Rev"},{"key":"2026100909105801400_cit26","doi-asserted-by":"publisher","first-page":"105386","DOI":"10.1016\/j.arabjc.2023.105386","article-title":"Synthesis Biological\nEvaluation and Network Pharmacology-Based Studies of 1,3,4-Oxadiazole\nBearing Azaphenols as Anticancer Agents","volume":"17","author":"Chen","year":"2024","journal-title":"Arabian\nJ. Chem"},{"key":"2026100909105801400_cit27","unstructured":"PharmMapper.\n          \n          PharmMapper Server. https:\/\/www.lilab-ecust.cn\/pharmmapper\/ (Accessed April 8, 2025)."},{"key":"2026100909105801400_cit28","first-page":"1779","article-title":"Integrating Network\nPharmacology and Experimental Validation to Decipher\nthe Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis","volume":"12","author":"Liang","year":"2021","journal-title":"Front. Pharmacol"},{"key":"2026100909105801400_cit29","unstructured":"GeneCards.\n          \n          The Human Gene Database. (Accessed\nApril 8, 2025).https:\/\/www.genecards.org\/."},{"key":"2026100909105801400_cit30","doi-asserted-by":"publisher","first-page":"6944792","DOI":"10.1155\/2022\/6944792","article-title":"Network Pharmacology-Based\nInvestigation\non the Mechanism of the JinGuanLan Formula in Treating Acne Vulgaris","volume":"13","author":"Gholais","year":"2022","journal-title":"Front. Pharmacol"},{"key":"2026100909105801400_cit31","unstructured":"Oliveros, J. C. V.\n          \n          An Interactive\nTool for Comparing Lists with Venn Diagrams; BioinfoGP, CNB-CSIC: Madrid, Spain, (Accessed April 8, 2025).https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/."},{"key":"2026100909105801400_cit32","doi-asserted-by":"publisher","first-page":"7228","DOI":"10.3390\/cimb45090457","article-title":"Molecular\nDocking Integrated with Network Pharmacology\nExplores the Therapeutic Mechanism of Cannabis sativa against Type 2 Diabetes","author":"Manuel","year":"2023","journal-title":"J. Biomol. Struct.\nDyn"},{"key":"2026100909105801400_cit33","unstructured":"STRING Database.\n          \n          STRING V12.0. https:\/\/version-12-0.string-db.org. (Accessed April 9, 2025)."},{"key":"2026100909105801400_cit34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A Free Online\nPlatform for Data Visualization and Graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"2026100909105801400_cit35","unstructured":"DAVID Bioinformatics Resources. (Accessed\nApril 26, 2025).https:\/\/davidbioinformatics.nih.gov\/."},{"key":"2026100909105801400_cit36","unstructured":"SRplot.\n          \n          Bioinformatics Online Analysis\nPlatform. https:\/\/www.bioinformatics.com.cn\/en. (Accessed April 26, 2025)."},{"key":"2026100909105801400_cit38","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.7314\/APJCP.2015.16.8.3383","article-title":"Portulaca oleracea Seed Oil Exerts\nCytotoxic Effects\non Human Liver Cancer (HepG2) and Human Lung Cancer (A-549) Cell Lines","volume":"16","author":"Al-Sheddi","year":"2015","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"2026100909105801400_cit39","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1021\/acsomega.9b03425","article-title":"Facially\nAmphiphilic Cholic Acid-Lysine\nConjugates as Promising Antimicrobials","volume":"5","author":"Singla","year":"2020","journal-title":"ACS\nOmega"},{"key":"2026100909105801400_cit40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-023-00853-2","article-title":"Network Pharmacology:\nA Bright Guiding Light on the Way to Explore\nPersonalized Precise Medication of Traditional Chinese Medicine","volume":"18","author":"Li","year":"2023","journal-title":"Chin Med"},{"issue":"10","key":"2026100909105801400_cit41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5414\/CPP38476","article-title":"Effect of Food on the\nPharmacokinetics\nand Bioavailability of Oral Imiquimod Relative to a Subcutaneous Dose","volume":"38","author":"Soria","year":"2000","journal-title":"Int. J. Clin Pharmacol Ther"},{"issue":"12","key":"2026100909105801400_cit42","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1128\/AAC.47.12.3846-3852.2003","article-title":"Randomized\nSingle-Blind, Placebo-Controlled Study of Topical Application of the\nImmune Response Modulator Resiquimod in Healthy Adults","volume":"47","author":"Sauder","year":"2003","journal-title":"Antimicrob. Agents Chemother"},{"issue":"1","key":"2026100909105801400_cit43","doi-asserted-by":"publisher","first-page":"12202","DOI":"10.1038\/s41598-026-46534-6","article-title":"TLR7\/8\nSignaling Balances Cytokine Responses in Neonatal\nMonocytes","volume":"16","author":"Dreschers","year":"2026","journal-title":"Sci. Rep"}],"container-title":["ACS Pharmacology &amp; Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsptsci.6c00263","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article-pdf\/9\/10\/2821\/68553648\/acsptsci.6c00263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article-pdf\/9\/10\/2821\/68553648\/acsptsci.6c00263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:49:42Z","timestamp":1791553782000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article\/9\/10\/2821\/5432588\/Integrated-In-Silico-and-Experimental-Insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,18]]},"published-print":{"date-parts":[[2026,10,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acsptsci.6c00263","relation":{},"ISSN":["2575-9108"],"issn-type":[{"value":"2575-9108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}